Health Care · Health Care Equipment
Edwards Lifesciences: revenue, profit and cash flow
In fiscal 2025, Edwards Lifesciences had revenue of $6.07B, up 9.3% a year on average since 2015, and net income of $1.07B (17.7% of revenue). It has 11% fewer shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +11.5% vs 2024
- Ticker
- EW · NYSE
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- Irvine, California
- Founded
- 1958
- In the S&P 500 since
- April 1, 2011
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Edwards Lifesciences Corp · CIK 0001099800
Revenue and net income
Revenue went from $1.24B in 2008 to $6.07B in 2025.
Diluted earnings per share
Diluted EPS went from $0.18 in 2008 to $1.83 in 2025. Ten-year growth: 9.3% a year.
Shares outstanding
11.4% fewer shares in 2025 than in 2015 (661M → 586M): buybacks outweighed new shares.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $1.33B in 2025, 22.0% of revenue.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|
| 2025 | $6.07B | $1.07B | 17.7% | $1.83 | 586M | $1.6B | $260M | $1.33B |
| 2024 | $5.44B | $4.17B | 76.7% | $6.97 | 599M | $542M | $252M | $290M |
| 2023 | $5.01B | $1.4B | 28.0% | $2.30 | 609M | $896M | $253M | $643M |
| 2022 | $4.46B | $1.52B | 34.1% | $2.44 | 624M | $1.22B | $245M | $974M |
| 2021 | $5.23B | $1.5B | 28.7% | $2.38 | 631M | $1.73B | $326M | $1.41B |
| 2020 | $4.39B | $823M | 18.8% | $1.30 | 632M | $1.05B | $407M | $647M |
| 2019 | $4.35B | $1.05B | 24.1% | $1.64 | 637M | $1.18B | $254M | $928M |
| 2018 | $3.72B | $722M | 19.4% | $1.13 | 641M | $927M | $239M | $688M |
| 2017 | $3.44B | $584M | 17.0% | $0.90 | 648M | $1.0B | $168M | $833M |
| 2016 | $2.96B | $570M | 19.2% | $0.87 | 653M | $704M | $176M | $528M |
| 2015 | $2.49B | $495M | 19.8% | $0.75 | 661M | $550M | $103M | $447M |
| 2014 | $2.32B | $811M | 34.9% | $1.25 | 651M | $1.02B | $82.9M | $939M |
| 2013 | $2.05B | $389M | 19.0% | $0.57 | 683M | $473M | $109M | $364M |
| 2012 | $1.9B | $292M | 15.3% | $0.41 | 710M | $362M | $109M | $253M |
| 2011 | $1.68B | $237M | 14.1% | $0.33 | 716M | $308M | $76.6M | $232M |
| 2010 | $1.45B | $218M | 15.1% | $0.30 | 715M | $251M | $61.8M | $190M |
| 2009 | $1.32B | $229M | 17.3% | $0.33 | 705M | $165M | $64M | $101M |
| 2008 | $1.24B | $129M | 10.4% | $0.18 | 715M | $153M | $50.6M | $103M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
Stock splits
Found in the filings; per-share figures and share counts on this page are on today’s share basis.
- 3-for-1 split · first reflected in a filing of July 27, 2020
- 2-for-1 split · first reflected in a filing of February 19, 2016
About these figures
- No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Equipment companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.